← Back
$DNLI All transactions

Denali Therapeutics Inc.

A

$ Value

$0

Shares

10,632

Price

$0

Filed

Nov 6

Insider

Name

Van Hauwermeiren Timothy

Title

CIK

0001816206

Roles

Director

Transaction Details

Transaction Date

2025-11-04

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

10,632

Footnotes

Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. The RSU award vests over a four-year period, with 1/4th of the shares vesting on each anniversary of the grant date (or, for the last tranche that otherwise would vest on the fourth anniversary of the grant date, on such anniversary or, if earlier, on the day prior to the Company's next annual meeting of stockholders occurring after the third anniversary of the grant date), provided that he remains a non-employee director through the applicable vesting date. | Includes 10,632 unvested RSUs. | 25% of the shares subject to the option shall vest on November 4, 2026, and an additional 1/48 of the shares subject to the option vest each month thereafter, subject to the Reporting Person remaining a non-employee director of the Issuer through each such date

Filing Info

Accession No.

0001816206-25-000007

Form Type

4

Issuer CIK

0001714899

Van Hauwermeiren Timothy's History

Date Ticker Type Value
2025-11-04 DNLI A $0
2025-11-04 DNLI A $0
2025-06-26 LXEO A $0
2025-05-13 ITOS M $96K
2025-05-13 ITOS M $0

Other Insiders at DNLI (90d)

No other insider activity at this issuer in the last 90 days.